Combination treatment in hypertension: The VeraTran Study

American Journal of Hypertension

Volumn 10, Issue 7 SUPPL. 1, 1997, Pages

  Mancia, Giuseppe ^a   Omboni, Stefano ^b   Grassi, Guido ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

Ambulatory blood pressure; Angiotensin converting enzyme inhibitors; Antihypertensive treatment; Calcium antagonists; Combination treatment; Compliance

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL; VERAPAMIL;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; INDOLES; VERAPAMIL;

EID: 0030787540     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mancia G, Mangoni AA, Pailla M, Rivolta MR: Guidelines for the treatment of hypertension: a commentary. Curr Ther Res 1996;57:3-15.
2. Mancia G, Grassi G: Combination treatment of hypertension. High Blood Pressure 1994;3(4, suppl):5-7.
3. Mancia G, Stella ML, Pozzi M, Grassi G: Treatment of hypertension: general aspects. J Cardiovasc Pharmacol 1996;28(suppl 4):S23-S28.
4. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
5. Ferrario M, Sega R, Cesana G: Lessons from the MONICA Study in northern Italy. J Hypertens 1991; 9(suppl 3):S7-S14.
6. Poulter NR. Treatment of hypertension: a clinical epidemiologist's view. J Cardiovasc Pharmacol 1991; 18(suppl 2):S35-S38.
7. Vaisse B, Herpin D, Delage Y, Poggi L: Antihypertensive treatments: drug efficacy effect and initial ambulatory blood pressure. Arch Mal Coeur Vaiss 1991;84: 1153-1157.
8. Trenkwalder P, Ruland D, Stender M, et al: Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly. J Hypertens 1994;12:709-716.
9. Gatley MS: To be taken as directed. J R Coll Gen Prac 1968;16:39-44.
10. Urquhart J: Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 1996;17(suppl A):8-15.
11. Guidelines Sub-Committee: 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1993;11:905-918.
12. The VeraTran Study Group: Effects of verapamil, trandolapril and their fixed combination on 24 hour blood pressure: the VeraTran Study. Am J Hypertens (in press).
13. Trazzi S, Mutti E, Frattola A, et al: Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies of antihypertensive treatment. J Hypertens 1991;9:115-119.
14. Conway J, Coats A: Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens 1989;7(suppl 3):S29-S32.
15. Mancia G: Ambulatory blood pressure monitoring: research and clinical implications. J Hypertens 1990; 8(suppl 7):S1-S13.
16. Mancia G, Zanchetti A, Agabiti-Rosei E, et al: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. The SAMPLE Study. Circulation 1997;95:1464-1470.
17. Mancia G, Omboni S, Parati G, et al: Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;8:311-315.
18. Mancia G, Omboni S, Ravogli A, et al: Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Pressure 1995;4:148-156.